Development of Postnatal Mobile Support Application
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03415321 |
|
Recruitment Status :
Completed
First Posted : January 30, 2018
Last Update Posted : June 23, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Postpartum Depression Postnatal Complication Nurse's Role | Device: Postpartum Mobile Support Application | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 124 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | A randomized controlled trial with a two-group pre-test and post-test design. |
| Masking: | Double (Investigator, Outcomes Assessor) |
| Primary Purpose: | Supportive Care |
| Official Title: | Development of Postnatal Mobile Support Application and Evaluation of the Effectiveness of Mothers' Anxiety and Postpartum Depression Symptoms: Pre-Test Post-Test Randomized Controlled Study |
| Actual Study Start Date : | April 4, 2019 |
| Actual Primary Completion Date : | July 30, 2019 |
| Actual Study Completion Date : | February 20, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Intervention group
Postpartum Mobile Support Application
|
Device: Postpartum Mobile Support Application
Women in the experimental group will use the Postpartum Mobile Support Application during six weeks after birth. Women will be evaluated three times in total, one for the first day after birth, second for the seventh day after birth and the last for the sixth week after birth. Short messages and calls will be remind of women's Postpartum Mobile Support Application use |
|
No Intervention: Control Group
Routine care
|
- Edinburgh Postnatal Depression Scale [ Time Frame: Postpartum 6 weeks ]Edinburgh Postnatal Depression Scale (EPDS) is a 10-item self-report scale that evaluates depressive symptoms just after delivery developed by Cox et al. (1987). EPDS will be used to assess depression in fathers and mothers. Each item is scored on a four-point scale(0-3), the minimum and maximum scores being 0 and 30,respectively. The prevalence of depression will be identified using the recommended cut-off point of 13 or above. The following severity ranges were established for the EPDS: None or minimal depression (0-6), Mild depression (7-13), Moderate depression (14-19), Severe depression (19-30).The EPDS score should not override clinical judgment. A careful clinical assessment should be carried out to confirm the diagnosis.
- State-Trait Anxiety Inventory [ Time Frame: Postpartum 1th day and 6 weeks ]State-Trait Anxiety Inventory (STAI) is self-report questionnaire consists of two subscales each containing 40 items, 20 items allocated to each of the S-Anxiety and T-Anxiety subscales. It has 20 items for assessing trait anxiety and 20 for state anxiety. State anxiety items include: "I am tense; I am worried" and "I feel calm; I feel secure." Trait anxiety items include: "I worry too much over something that really doesn't matter" and "I am content; I am a steady person." All items are rated on a 4-point scale. Higher scores indicate greater anxiety. The scores obtained from the scale range theoretically from 20 to 80. Bigger score indicates high anxiety level; small score indicates low anxiety level.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 55 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Giving birth full term 39 weeks 0 days and 40 weeks 6 days (ACOG 2013)
- Having a phone with Android feature and having an internet connection
- Baby's normal birth weight and having APGAR score 8 and above
Exclusion Criteria:
- Adolescent pregnants
- Having anxiety and depression
- Complication developments in the mother or newborn after delivery
- Newborn stay in the intensive care unit
- Visually impaired, hearing impaired
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03415321
| Turkey | |
| Necmettin Erbakan University | |
| Konya, Turkey, Konya | |
| Principal Investigator: | Vesile KOÇAK | Researcher |
| Responsible Party: | Vesile KOÇAK, Principal Investigator, Necmettin Erbakan University |
| ClinicalTrials.gov Identifier: | NCT03415321 |
| Other Study ID Numbers: |
NecmettinEU |
| First Posted: | January 30, 2018 Key Record Dates |
| Last Update Posted: | June 23, 2020 |
| Last Verified: | June 2020 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Postpartum, Nurse, Mothers, Anxiety, Depression, Mobile Support |
|
Depression, Postpartum Depression Depressive Disorder Behavioral Symptoms |
Mood Disorders Mental Disorders Puerperal Disorders Pregnancy Complications |

